o
^ 5 - &o
UTILITY PATENT APPLICATION TRANSMITTAL (Large Entity)
Only for new nonprovisional applications under 37 C.F.R. 1.53(b)
Docket No.
2831 -E
Express Mail Label No.:
EL333159549US
TO THE ASSISTANT COMMISSIONER FOR PATENTS
BOX PATENT APPLICATION
Washington, D.C. 20231
Transmitted herewith for filing under 35 U.S.C. 1 1 1 (a) and 37 C.F.R. 1 .53(b) is a new utility patent g*=*
application for an invention entitled: ^
ANTAGONISTS OF INTERLEUKIN-15
and invented by:
Kenneth H. Grabstein, residing at Mercer Island, Washington, Dean K. Pettit, residing at
Seattle, Washington, and Raymond J. Paxton, residing at Bellevue, Washington.
If a CONTINUING APPLICATION, check appropriate box and supply the requisite information:
EI Continuation □ Divisional □ Continuation-in-part (CIP)
of prior application No.: 09/196,427
Enclosed are:
Application Elements
1 . El Filing fee as calculated and transmitted as described below
2. [El Specification including claims and abstract ( 28 pages total)
3. □ Drawing(s); Number of Sheets
4. lEl Oath or Declaration
a. □ Newly executed
b. El Copy from a prior application (37.C.F.R. 1 .63(d)) (for continuation/divisional
application only)
c. [EI With Power of Attorney □ Without Power of Attorney
d. □ DELETION OF INVENTOR(S)
Signed statement attached deleting inventor(s) named in prior application, see 37
C.F.R. 1.63(d)(2) and 1.33(b).
5. El Incorporation by Reference (usable if Box 4b is checked)
The entire disclosure of the prior application from which a copy of the oath or
declaration is supplied under Box 4b, is considered as being part of the disclosure of
the accompanying application and is hereby incorporated by reference therein.
6. □ Computer Program in Microfiche (Appendix)
7. [El Nucleotide and/or Amino Acid Sequence Submission
a. El Paper copy
Pages 21 - 25 of specification
□ Separately numbered pages .
b. □ Computer Readable Copy
c. EI Statement Verifying Identical Paper and Computer Readable Copy
d. El Statement under 37 C.F.R. 1 .821 (e) in lieu of Computer Readable Copy
•
UTILITY PATENT APPLICATION TRANSMITTAL (Large Entity)
D cket No.: 2831 -E
Accompanying Application Parts
8. □ Assignment
a. □ Executed original Assignment and Recordation Form enclosed
b. □ Prior application is assigned of record to Immunex Corporation
(reel frame )
9. □ 37 C.F.R. 3.73(B) Statement (when there is an assignee)
10. (El Preliminary Amendment
11. (El Acknowledgment postcard
1 2. m Certificate of Mailing by Express Mail (Label No.: EL3331 59549US)
1 3. □ Certified Copy of Priority Document(s) (if foreign priority is claimed)
14. □ Additional Enclosures (please identify beloW):
Fee Calculation and Transmittal
CLAIMS AS FILED (after any Preliminary Amendment submitted herewith)
For
# Filed
# Allowed
# Extra
Rate
Fee
Total Claims
6
- 20 =
0
x $18.00
$0.00
Indep. Claims
1
- 3 =
0
x $78.00
$0.00
Multiple Dependent Claims (check if applicable) □
$0.00
BASIC FEE
$690.00
OTHER FEE (specify purpose)
$0.00
TOTAL FILING FEE
$690.00
M The Commissioner is hereby authorized to charge and credit Deposit Account No. 09-0089 as
described below. A copy of this sheet is enclosed.
\E\ Charge the amount of $690 as a filing fee.
IEI Credit any overpayment.
[El Charge any additional fees required under 37 C.F.R. 1.16 and 1.17.
Correspondence address: Julie K. Smith, Ph.D
Registration No. 38,61
Immunex Corporation
Law Department
51 University Street Dated: May 25, 2000
Seattle, Washington 98101
lelephone: (206) 587^0430
be251001 5/25/00
2
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
In the Application of:
Docket No.: 283 1-E
Kenneth H. Grabstein, Dean K. Petti t,
and Raymond J. Paxton
Serial No.:
—to be assigned—
Art Unit:
unknown
Filed:
May 25, 2000
Examiner:
unknown
For:
ANTAGONISTS OF INTERLEUKIN- 1 5
CERTIFICATE OF MAILING BY EXPRESS MAIL
BOX PATENT APPLICATION
Assistant Commissioner for Patents
Washington, D.C. 20231
EXPRESS MAIL LABEL NUMBER: EL333159549US
I hereby certify that the enclosed correspondence is being deposited with the United
States Postal Service "Express Mail Post Office to Addressee" service under 37 CFR §1.10
on the date listed below, and is addressed to BOX PATENT APPLICATION, Assistant
Commissioner for Patents, Washington, D.C. 20231.
Patent Application Transmittal Letter (2 pages + copy)
Preliminary Amendment (2 pages), including replacement paper copy
of Sequence Listing (pages 21-25)
Specification, Claims and Abstract (28 pages)
Statement Under 37 CFR § 1.821 (e) and (f)
Copy of Originally filed Declaration and Power of Attorney
Postcard
Signd
^- Nanci M.^Certsdn
Dat<